Published Online:https://doi.org/10.1148/rg.336135501

FDG PET/CT imaging patterns suggestive of perineural spread are illustrated, with emphasis on the neuroanatomy of commonly involved cranial nerves, clinical and prognostic implications, and possible diagnostic pitfalls.

Certain tumors of the head and neck use peripheral nerves as a direct conduit for tumor growth away from the primary site by a process known as perineural spread. Perineural spread is associated with decreased survival and a higher risk of local recurrence and metastasis. Radiologists play an important role in the assessment and management of head and neck cancer, and positron emission tomography/computed tomography (PET/CT) with 2-[fluorine 18]fluoro-2-deoxy-d-glucose (FDG) is part of the work-up and follow-up of many affected patients. Awareness of abnormal FDG uptake patterns within the head and neck is fundamental for diagnosing perineural spread. The cranial nerves most commonly affected by perineural spread are the trigeminal and facial nerves. Risk of perineural spread increases with a midface location of the tumor, male gender, increasing tumor size, recurrence after treatment, and poor histologic differentiation. Focal or linear increased FDG uptake along the V2 division of the trigeminal nerve or along the medial surface of the mandible, or asymmetric activity in the masticator space, foramen ovale, or Meckel cave should raise suspicion for perineural spread. If FDG PET/CT findings suggest perineural spread, the radiologist should look at available results of other imaging studies, especially magnetic resonance imaging, to confirm the diagnosis. Knowledge of common FDG PET/CT patterns of neoplastic involvement along the cranial nerves and potential diagnostic pitfalls is of the utmost importance for adequate staging and treatment planning.

© RSNA, 2013

References

  • 1 Johnston M, Yu E, Kim J. Perineural invasion and spread in head and neck cancer. Expert Rev Anticancer Ther 2012;12(3):359–371. Crossref, MedlineGoogle Scholar
  • 2 Balamucki CJ, Mancuso AA, Amdur RJ, et al.. Skin carcinoma of the head and neck with perineural invasion. Am J Otolaryngol 2012;33(4):447–454. Crossref, MedlineGoogle Scholar
  • 3 Fowler BZ, Crocker IR, Johnstone PA. Perineural spread of cutaneous malignancy to the brain: a review of the literature and five patients treated with stereotactic radiotherapy. Cancer 2005;103(10): 2143–2153. Crossref, MedlineGoogle Scholar
  • 4 Liebig C, Ayala G, Wilks JA, Berger DH, Albo D. Perineural invasion in cancer: a review of the literature. Cancer 2009;115(15):3379–3391. Crossref, MedlineGoogle Scholar
  • 5 Chatterjee S, Frew J, Mott J, et al.. Variation in radiotherapy target volume definition, dose to organs at risk and clinical target volumes using anatomic (computed tomography) versus combined anatomic and molecular imaging (positron emission tomography/computed tomography): intensity-modulated radiotherapy delivered using a tomotherapy Hi Art machine—final results of the VortigERN study. Clin Oncol (R Coll Radiol) 2012;24(10):e173–e179. Crossref, MedlineGoogle Scholar
  • 6 Zollinger LV, Wiggins RH. A head and neck radiologist’s perspective on best practices for the usage of PET/CT scans for the diagnosis and treatment of head and neck cancers. Arch Otolaryngol Head Neck Surg 2012;138(8):754–758. Crossref, MedlineGoogle Scholar
  • 7 Moulin-Romsee G, Benamor M, Neuenschwander S. Desmoplastic neurotropic melanoma in a patient with trigeminal neuralgia: FDG PET/CT and MRI. Clin Nucl Med 2008;33(5):353–355. Crossref, MedlineGoogle Scholar
  • 8 Conrad GR, Sinha P, Holzhauer M. Perineural spread of skin carcinoma to the base of the skull: detection with FDG PET and CT fusion. Clin Nucl Med 2004;29(11):717–719. Crossref, MedlineGoogle Scholar
  • 9 Liu SH, Kao PF, Chiu CH, Liu DW, Hsieh HJ, Chen PR. Perineural recurrence of buccal cancer demonstrated by F-18 FDG PET/CT. Clin Nucl Med 2010;35(3):189–191. Crossref, MedlineGoogle Scholar
  • 10 Nguyen BD, Roarke MC. Salivary duct carcinoma with perineural spread to facial canal: F-18 FDG PET/CT detection. Clin Nucl Med 2008;33(12): 925–928. Crossref, MedlineGoogle Scholar
  • 11 Branstetter BF, Blodgett TM, Zimmer LA, et al.. Head and neck malignancy: is PET/CT more accurate than PET or CT alone? Radiology 2005;235(2):580–586. LinkGoogle Scholar
  • 12 Anzai Y, Carroll WR, Quint DJ, et al.. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-d-glucose PET and MR imaging diagnoses. Radiology 1996;200(1):135–141. LinkGoogle Scholar
  • 13 Kitagawa Y, Nishizawa S, Sano K, et al.. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma. J Nucl Med 2003;44(2):198–206. MedlineGoogle Scholar
  • 14 Kubota K, Yokoyama J, Yamaguchi K, et al.. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT. Eur J Nucl Med Mol Imaging 2004;31(4):590–595. Crossref, MedlineGoogle Scholar
  • 15 Sadick M, Schoenberg SO, Hoermann K, Sadick H. Current oncologic concepts and emerging techniques for imaging of head and neck squamous cell cancer. GMS Curr Top Otorhinolaryngol Head Neck Surg 2012;11:Doc08. MedlineGoogle Scholar
  • 16 Laubenbacher C, Saumweber D, Wagner-Manslau C, et al.. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med 1995; 36(10):1747–1757. MedlineGoogle Scholar
  • 17 Subramaniam RM, Truong M, Peller P, Sakai O, Mercier G. Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer. AJNR Am J Neuroradiol 2010;31(4): 598–604. Crossref, MedlineGoogle Scholar
  • 18 Strobel K, Haerle SK, Stoeckli SJ, et al.. Head and neck squamous cell carcinoma (HNSCC): detection of synchronous primaries with (18)F-FDG-PET/CT. Eur J Nucl Med Mol Imaging 2009;36(6): 919–927. Crossref, MedlineGoogle Scholar
  • 19 Mak D, Corry J, Lau E, Rischin D, Hicks RJ. Role of FDG-PET/CT in staging and follow-up of head and neck squamous cell carcinoma. Q J Nucl Med Mol Imaging 2011;55(5):487–499. MedlineGoogle Scholar
  • 20 Pryor DI, Porceddu SV, Scuffham PA, Whitty JA, Thomas PA, Burmeister BH. Economic analysis of FDG-PET-guided management of the neck after primary chemoradiotherapy for node-positive head and neck squamous cell carcinoma. Head Neck 2012; Sep 18. [Epub ahead of print] MedlineGoogle Scholar
  • 21 Sher DJ, Tishler RB, Annino D, Punglia RS. Cost-effectiveness of CT and PET-CT for determining the need for adjuvant neck dissection in locally advanced head and neck cancer. Ann Oncol 2010;21(5):1072–1077. Crossref, MedlineGoogle Scholar
  • 22 Abe Y, Matsuzawa T, Fujiwara T, et al.. Assessment of radiotherapeutic effects on experimental tumors using 18F-2-fluoro-2-deoxy-D-glucose. Eur J Nucl Med 1986;12(7):325–328. Crossref, MedlineGoogle Scholar
  • 23 Lowe VJ, Dunphy FR, Varvares M, et al.. Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography. Head Neck 1997;19(8):666–674. Crossref, MedlineGoogle Scholar
  • 24 Gupta T, Master Z, Kannan S, et al.. Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 2011;38(11):2083–2095. Crossref, MedlineGoogle Scholar
  • 25 Ong SC, Schöder H, Lee NY, et al.. Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for locoregional advanced head and neck cancer. J Nucl Med 2008;49(4):532–540. Crossref, MedlineGoogle Scholar
  • 26 Rege SD, Chaiken L, Hoh CK, et al.. Change induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: quantitation with PET. Radiology 1993;189(3): 807–812. LinkGoogle Scholar
  • 27 Blodgett TM, Fukui MB, Snyderman CH, et al.. Combined PET-CT in the head and neck. I. Physiologic, altered physiologic, and artifactual FDG uptake. RadioGraphics 2005;25(4):897–912. LinkGoogle Scholar
  • 28 Peterson AM, Meltzer CC, Evanson EJ, Flickinger JC, Kondziolka D. MR imaging response of brain metastases after gamma knife stereotactic radiosurgery. Radiology 1999;211(3):807–814. LinkGoogle Scholar
  • 29 Wong RJ, Lin DT, Schöder H, et al.. Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol 2002; 20(20):4199–4208. Crossref, MedlineGoogle Scholar
  • 30 Jabour BA, Choi Y, Hoh CK, et al.. Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation. Radiology 1993;186(1):27–35. LinkGoogle Scholar
  • 31 Wahl RL, Quint LE, Cieslak RD, Aisen AM, Koeppe RA, Meyer CR. “Anatometabolic” tumor imaging: fusion of FDG PET with CT or MRI to localize foci of increased activity. J Nucl Med 1993;34(7): 1190–1197. MedlineGoogle Scholar
  • 32 Ginsberg LE. Imaging of perineural tumor spread in head and neck cancer. Semin Ultrasound CT MR 1999;20(3):175–186. Crossref, MedlineGoogle Scholar
  • 33 Binmadi NO, Basile JR. Perineural invasion in oral squamous cell carcinoma: a discussion of significance and review of the literature. Oral Oncol 2011; 47(11):1005–1010. Crossref, MedlineGoogle Scholar
  • 34 Marchesi F, Piemonti L, Mantovani A, Allavena P. Molecular mechanisms of perineural invasion: a forgotten pathway of dissemination and metastasis. Cytokine Growth Factor Rev 2010;21(1):77–82. Crossref, MedlineGoogle Scholar
  • 35 Iwamoto S, Odland PB, Piepkorn M, Bothwell M. Evidence that the p75 neurotrophin receptor mediates perineural spread of desmoplastic melanoma. J Am Acad Dermatol 1996;35(5 Pt 1):725–731. Crossref, MedlineGoogle Scholar
  • 36 Barrett AW, Speight PM. Perineural invasion in adenoid cystic carcinoma of the salivary glands: a valid prognostic indicator? Oral Oncol 2009;45(11): 936–940. Crossref, MedlineGoogle Scholar
  • 37 Gandhi D, Gujar S, Mukherji SK. Magnetic resonance imaging of perineural spread of head and neck malignancies. Top Magn Reson Imaging 2004; 15(2):79–85. Crossref, MedlineGoogle Scholar
  • 38 Chang PC, Fischbein NJ, McCalmont TH, et al.. Perineural spread of malignant melanoma of the head and neck: clinical and imaging features. AJNR Am J Neuroradiol 2004;25(1):5–11. MedlineGoogle Scholar
  • 39 Caldemeyer KS, Mathews VP, Righi PD, Smith RR. Imaging features and clinical significance of perineural spread or extension of head and neck tumors. RadioGraphics 1998;18(1):97–110. LinkGoogle Scholar
  • 40 Parker GD, Harnsberger HR. Clinical-radiologic issues in perineural tumor spread of malignant diseases of the extracranial head and neck. RadioGraphics 1991;11(3):383–399. LinkGoogle Scholar
  • 41 Warden KF, Parmar H, Trobe JD. Perineural spread of cancer along the three trigeminal divisions. J Neuroophthalmol 2009;29(4):300–307. Crossref, MedlineGoogle Scholar
  • 42 Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist 2007;12(1):20–37. Crossref, MedlineGoogle Scholar
  • 43 Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 2005; 114(5):806–816. Crossref, MedlineGoogle Scholar
  • 44 Chirilă M, Bolboacă SD, Cosgarea M, Tomescu E, Mureşan M. Perineural invasion of the major and minor nerves in laryngeal and hypopharyngeal cancer. Otolaryngol Head Neck Surg 2009;140(1): 65–69. Crossref, MedlineGoogle Scholar
  • 45 Bell RB, Dierks EJ, Homer L, Potter BE. Management and outcome of patients with malignant salivary gland tumors. J Oral Maxillofac Surg 2005;63(7):917–928. Crossref, MedlineGoogle Scholar
  • 46 Majoie CB, Hulsmans FJ, Verbeeten B, et al.. Perineural tumor extension along the trigeminal nerve: magnetic resonance imaging findings. Eur J Radiol 1997;24(3):191–205. Crossref, MedlineGoogle Scholar
  • 47 McHugh CH, Roberts DB, El-Naggar AK, et al.. Prognostic factors in mucoepidermoid carcinoma of the salivary glands. Cancer 2012;118(16): 3928–3936. Crossref, MedlineGoogle Scholar
  • 48 Goepfert H, Dichtel WJ, Medina JE, Lindberg RD, Luna MD. Perineural invasion in squamous cell skin carcinoma of the head and neck. Am J Surg 1984; 148(4):542–547. Crossref, MedlineGoogle Scholar
  • 49 Woodruff WW, Yeates AE, McLendon RE. Perineural tumor extension to the cavernous sinus from superficial facial carcinoma: CT manifestations. Radiology 1986;161(2):395–399. LinkGoogle Scholar
  • 50 Majoie CB, Hulsmans FJ, Castelijns JA, Walter A, Bras J, Peeters FL. Perineural tumor extension of facial malignant melanoma: CT and MRI. J Comput Assist Tomogr 1993;17(6):973–975. Crossref, MedlineGoogle Scholar
  • 51 Batsakis JG, Raymond AK. Desmoplastic melanoma. Ann Otol Rhinol Laryngol 1994;103(1): 77–79. Crossref, MedlineGoogle Scholar
  • 52 Catalano PJ, Sen C, Biller HF. Cranial neuropathy secondary to perineural spread of cutaneous malignancies. Am J Otol 1995;16(6):772–777. MedlineGoogle Scholar
  • 53 Mendenhall WM, Ferlito A, Takes RP, et al.. Cutaneous head and neck basal and squamous cell carcinomas with perineural invasion. Oral Oncol 2012;48(10):918–922. Crossref, MedlineGoogle Scholar
  • 54 Tai SK, Li WY, Yang MH, et al.. Treatment for T1-2 oral squamous cell carcinoma with or without perineural invasion: neck dissection and postoperative adjuvant therapy. Ann Surg Oncol 2012;19(6): 1995–2002. Crossref, MedlineGoogle Scholar
  • 55 Expert Panel on Radiation Oncology-Head and NeckSalama JK, Saba N, et al.. ACR appropriateness criteria® adjuvant therapy for resected squamous cell carcinoma of the head and neck. Oral Oncol 2011;47(7):554–559. Crossref, MedlineGoogle Scholar
  • 56 Shen C, Xu T, Huang C, Hu C, He S. Treatment outcomes and prognostic features in adenoid cystic carcinoma originated from the head and neck. Oral Oncol 2012;48(5):445–449. Crossref, MedlineGoogle Scholar
  • 57 Dunn M, Morgan MB, Beer TW. Perineural invasion: identification, significance, and a standardized definition. Dermatol Surg 2009;35(2):214–221. Crossref, MedlineGoogle Scholar
  • 58 Farasat S, Yu SS, Neel VA, et al.. A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics. J Am Acad Dermatol 2011;64(6):1051–1059. Crossref, MedlineGoogle Scholar
  • 59 Lee KJ, Abemayor E, Sayre J, Bhuta S, Kirsch C. Determination of perineural invasion preoperatively on radiographic images. Otolaryngol Head Neck Surg 2008;139(2):275–280. Crossref, MedlineGoogle Scholar
  • 60 Panizza B, Solares CA, Redmond M, Parmar P, O’Rourke P. Surgical resection for clinical perineural invasion from cutaneous squamous cell carcinoma of the head and neck. Head Neck 2012;34(11): 1622–1627. Crossref, MedlineGoogle Scholar
  • 61 Meng FY, Ko JY, Lou PJ, et al.. The determining risk factors for treatment outcomes in patients with squamous cell carcinoma of the hard palate. Ann Surg Oncol 2012;19(6):2003–2010. Crossref, MedlineGoogle Scholar
  • 62 Nemec SF, Herneth AM, Czerny C. Perineural tumor spread in malignant head and neck tumors. Top Magn Reson Imaging 2007;18(6):467–471. Crossref, MedlineGoogle Scholar
  • 63 Chong VF, Fan YF. Hypoglossal nerve palsy in nasopharyngeal carcinoma. Eur Radiol 1998;8(6): 939–945. Crossref, MedlineGoogle Scholar
  • 64 Ong CK, Chong VF. Imaging of perineural spread in head and neck tumours. Cancer Imaging 2010;10(Spec No A):S92–S98. Crossref, MedlineGoogle Scholar
  • 65 Sheth S, Branstetter BF 4th, Escott EJ. Appearance of normal cranial nerves on steady-state free precession MR images. RadioGraphics 2009;29(4): 1045–1055. LinkGoogle Scholar
  • 66 Fukui MB, Blodgett TM, Snyderman CH, et al.. Combined PET-CT in the head and neck. II. Diagnostic uses and pitfalls of oncologic imaging. RadioGraphics 2005;25(4):913–930. LinkGoogle Scholar
  • 67 Avril NE, Weber WA. Monitoring response to treatment in patients utilizing PET. Radiol Clin North Am 2005;43(1):189–204. Crossref, MedlineGoogle Scholar
  • 68 Rogers JW, Greven KM, McGuirt WF, et al.. Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy? Int J Radiat Oncol Biol Phys 2004;58(3):694–697. Crossref, MedlineGoogle Scholar
  • 69 Minn H, Paul R, Ahonen A. Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18 fluorodeoxyglucose. J Nucl Med 1988;29(9):1521–1525. MedlineGoogle Scholar
  • 70 Ronaghy A, Yaar R, Goldberg LJ, Mahalingam M, Bhawan J. Perineural involvement: what does it mean? Am J Dermatopathol 2010;32(5):469–476. Crossref, MedlineGoogle Scholar

Article History

Received: Jan 31 2013
Revision requested: Feb 26 2013
Revision received: Mar 15 2013
Accepted: Apr 9 2013
Published online: Oct 1 2013
Published in print: Oct 2013